PBM
Psyence Biomedical Ltd. Common Shares
NASDAQ: PBM · HEALTHCARE · BIOTECHNOLOGY
$6.59
+29.72% today
Updated 2026-04-30
Market cap
$16.17M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-389.98
Dividend yield
—
52W range
$2 – $75
Volume
3.0M
Psyence Biomedical Ltd. Common Shares (PBM) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — |
| Cost of revenue | — | — | $240.00 | $4268.00 |
| Gross profit | — | — | $-240.00 | $-4268.00 |
| Gross margin | — | — | — | — |
| R&D | $137237.00 | $1.61M | $954593.00 | $342168.00 |
| SG&A | $1.70M | $1.62M | $1.72M | $3.32M |
| Operating income | $-334290.00 | $-1.29M | $-2.75M | $-3.66M |
| Operating margin | — | — | — | — |
| EBITDA | $-334290.00 | $-1.29M | $-51.11M | $1.03M |
| EBITDA margin | — | — | — | — |
| EBIT | $-2.19M | $-1.29M | $-51.11M | $1.02M |
| Interest expense | — | $0.00 | $52941.00 | $9270.00 |
| Income tax | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $8.23M | $8.01M | $-51.16M | $1.01M |
| Net income growth (YoY) | — | -2.6% | -738.3% | +102.0% |
| Profit margin | — | — | — | — |